Predict your next investment

Venture Capital
ally-bridge.com

See what CB Insights has to offer

Investments

83

Portfolio Exits

22

Funds

4

Partners & Customers

3

About Ally Bridge Group

Ally Bridge Group (汇桥资本) is a global healthcare-focused investment group with a global healthcare investment portfolio in China, the United States, and Europe.

Ally Bridge Group Headquarter Location

Unit 3002-3004, 30th Floor Gloucester Tower, The Landmark, 15 Queen’s Road

Central,

Hong Kong

+852 31219699

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ally Bridge Group News

Syapse Raises $35M in Growth Funding

Jul 28, 2022

Syapse , a San Francisco, CA and New York-based evidence company dedicated to advancing real-world care, raised $35M in Growth funding. The round was led by Innovatus Capital Partners, with participation from existing investors including Ally Bridge Group, Merck Global Health Innovation Fund, Northpond Ventures, Revelation Alpine LLC, Safeguard Scientifics, and Social Capital. The company intends to use the funds to expand its focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer. Led by Ken Tarkoff, chief executive officer, Syapse is a company dedicated to extinguishing the fear and burden of oncology and other serious diseases by advancing real-world care. By combining clinical expertise with smart technologies, the company transforms data into evidence—and then into experience—in collaboration with a network of partners, who are committed to improving patients’ lives through community health systems. Syapse has expanded its Learning Health Network by partnering with some of the nation’s leading community health systems to support precision medicine strategies that are directed at improving clinical outcomes, reducing costs and enhancing the experience of their patients. In addition, the company has added life sciences partnerships with established biopharmaceutical companies. FinSMEs 27/07/2022

Ally Bridge Group Investments

83 Investments

Ally Bridge Group has made 83 investments. Their latest investment was in Syapse as part of their Unattributed VC on July 7, 2022.

CBI Logo

Ally Bridge Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/27/2022

Unattributed VC

Syapse

$35M

No

1

5/4/2022

Series F

Aerin Medical

$60M

Yes

1

3/10/2022

Series E

RefleXion

$80M

Yes

10

2/7/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

1/11/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/27/2022

5/4/2022

3/10/2022

2/7/2022

1/11/2022

Round

Unattributed VC

Series F

Series E

Series B

Series C

Company

Syapse

Aerin Medical

RefleXion

Subscribe to see more

Subscribe to see more

Amount

$35M

$60M

$80M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

10

10

10

Ally Bridge Group Portfolio Exits

22 Portfolio Exits

Ally Bridge Group has 22 portfolio exits. Their latest portfolio exit was AltheaDx on April 04, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/4/2022

Acquired

$99M

4

12/16/2021

Acq - P2P

$99M

4

12/2/2021

Acquired

$99M

5

10/8/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

7/16/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/4/2022

12/16/2021

12/2/2021

10/8/2021

7/16/2021

Exit

Acquired

Acq - P2P

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

4

5

10

10

Ally Bridge Group Acquisitions

2 Acquisitions

Ally Bridge Group acquired 2 companies. Their latest acquisition was Shandong Luoxin Pharmacy Group on March 15, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/15/2017

$99M

Take Private

1

8/14/2015

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

3/15/2017

8/14/2015

Investment Stage

Debt

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Take Private

Subscribe to see more

Sources

1

10

Ally Bridge Group Fund History

4 Fund Histories

Ally Bridge Group has 4 funds, including Ally Bridge Group-WTT Global Life Science Capital Partners.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/2/2020

Ally Bridge Group-WTT Global Life Science Capital Partners

2

4/30/2018

Ally Bridge Group Innovation Capital Partners III LP

Subscribe to see more

Subscribe to see more

$99M

10

Ally Bridge Group Capital Partners II LP

Subscribe to see more

Subscribe to see more

10

Ally Bridge Group Flagship Capital Partners LP

Subscribe to see more

Subscribe to see more

10

Closing Date

12/2/2020

4/30/2018

Fund

Ally Bridge Group-WTT Global Life Science Capital Partners

Ally Bridge Group Innovation Capital Partners III LP

Ally Bridge Group Capital Partners II LP

Ally Bridge Group Flagship Capital Partners LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

Sources

2

10

10

10

Ally Bridge Group Partners & Customers

3 Partners and customers

Ally Bridge Group has 3 strategic partners and customers. Ally Bridge Group recently partnered with Quantum Surgical, and LifeTech Scientific on April 4, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

4/4/2019

Partner

France, and China

Ally Bridge, LifeTech Scientific and Quantum Surgical Announce Three-Way China Joint Venture to Develop Innovative Surgical Robot for the Treatment of Liver Cancer

`` This is a win-win partnership , where LifeTech Scientific Corporation is introduced and advised by our strategic partner ABG to join forces with Quantum Surgical , a leading innovative surgical robot developer with a proven track record , '' said Yue-Hui Xie , Chairman and CEO of LifeTech Scientific Corporation .

4

1/1/2018

Partner

France

Subscribe to see more

Subscribe to see more

10

1/1/2018

Partner

China

Subscribe to see more

Subscribe to see more

10

Date

4/4/2019

1/1/2018

1/1/2018

Type

Partner

Partner

Partner

Business Partner

Country

France, and China

France

China

News Snippet

Ally Bridge, LifeTech Scientific and Quantum Surgical Announce Three-Way China Joint Venture to Develop Innovative Surgical Robot for the Treatment of Liver Cancer

`` This is a win-win partnership , where LifeTech Scientific Corporation is introduced and advised by our strategic partner ABG to join forces with Quantum Surgical , a leading innovative surgical robot developer with a proven track record , '' said Yue-Hui Xie , Chairman and CEO of LifeTech Scientific Corporation .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

Ally Bridge Group Team

7 Team Members

Ally Bridge Group has 7 team members, including current Founder, Chief Executive Officer, Chief Information Officer, Frank Yu.

Name

Work History

Title

Status

Arthur Kuan

Founder

Current

Frank Yu

Themes Investment Partners, Sculptor Capital Management, Goldman Sachs, Credit Suisse, and Moody's

Founder, Chief Executive Officer, Chief Information Officer

Current

Daniel Johnson

Trend Capital, Khronos Group, Morgan Stanley & Co., Tiger Management Corp, and PwC

Chief Financial Officer

Current

Andrew Lam

Senior Vice President

Current

Charles Chon

Managing Director

Current

Name

Arthur Kuan

Frank Yu

Daniel Johnson

Andrew Lam

Charles Chon

Work History

Themes Investment Partners, Sculptor Capital Management, Goldman Sachs, Credit Suisse, and Moody's

Trend Capital, Khronos Group, Morgan Stanley & Co., Tiger Management Corp, and PwC

Title

Founder

Founder, Chief Executive Officer, Chief Information Officer

Chief Financial Officer

Senior Vice President

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.